Skip to content

Effect of nirgundi siddha taila nabhi basti in pakwashayagata vata.

Open label single group clinical trial of nirgungi siddha taila nabhi basti in the management of pakwashayagata vata. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104772
Enrollment
68
Registered
2026-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

None listed

Sponsors

C.S.M.S.S. Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra India 431011
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group of 20 to 50 years , irrespective of gender , occupation or economic status . Patient of well defined sign and symtoms of pakwashayagataa vata . Patient Yogya for Nabhi Basti Patient willing for trial and giving written consent.

Exclusion criteria

Exclusion criteria: Patients below age of 20 to above 50 years. Ayogya for Nabhi Basti 3.Patients with other severe systemic disorders like uncontrolled Diabetes mellitus ,cardiac disorders,renal disorders. Emergency abdominal pathologies like appendicitis,ulcerative colitis,chron s disease.etc.

Design outcomes

Primary

MeasureTime frame
Reduces udarshool and anahaTimepoint: 7 days

Secondary

MeasureTime frame
Reduces antrakujan and kruchch purishataTimepoint: 7 days

Countries

India

Contacts

Public ContactDr Priti Gulab Nhayade

C.S.M.S.S. Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra India 431011

drmegha26@gmail.com8149888802

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026